Breaking News, Collaborations & Alliances

Hybio, YF Capital to Buy AMW

New owners to support further growth of AMW, invest in the development of new products & advance internationalization efforts

The owners of AMW GmbH are entering into an agreement to sell their shares in the specialty pharma company located in Warngau along with its subsidiary Endomedica GmbH located in Halle (Saale) to a consortium led by Hybio Pharmaceutical and YF capital.  The new owners intend to support the further growth of AMW, invest in the development of new products, and advance the company’s internationalization efforts. The sellers include AMW founders, healthcare investor SHS Gesellschaft für Beteili...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters